Quantum BioPharma Ltd. (QNTM) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 10.4M | 6.47M | 9.34M | 10.34M | 9.93M | 12.05M | 13.84M | 10.02M | 9.19M | 11.09M | 9.25M | 9.11M |
| Cash & Short-Term Investments | 10.07M | 6.17M | 1.08M | 1.53M | 3.54M | 7.2M | 6.61M | 3.33M | 2.09M | 3.51M | 4.37M | 5.67M |
| Cash Only | 4.36M | 1.9M | 445.94K | 1.5M | 3.52M | 6M | 3.12M | 3.31M | 1.33M | 2.76M | 3.63M | 5.67M |
| Short-Term Investments | 5.71M | 4.27M | 636.76K | 30.79K | 20.87K | 1.2M | 3.49M | 21.92K | 760.14K | 756.1K | 739.6K | 0 |
| Accounts Receivable | 209.21K | 230.63K | 2.94M | 3.23M | 3.41M | 3.81M | 6.98M | 6.48M | 6.83M | 7.42M | 4.08M | 2.93M |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 51.64K | 52.04K | 77.62K | 76.87K | 93.86K | 117.24K | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 37.12 | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 19.79K | 13.07K | 5.21M | 5.05M | 2.74M | 861.23K | 151.01K | 86.87K | 0 | 0 | 580.82K | 502.68K |
| Total Non-Current Assets | 4.57M | 4.67M | 4.81M | 4.95M | 4.94M | 5.07M | 5.18M | 5.22M | 6.25M | 6.39M | 9.7M | 12.3M |
| Property, Plant & Equipment | 148.02K | 169.04K | 190.75K | 228.17K | 109.32K | 130.38K | 137.28K | 73.12K | 105.1K | 120.42K | 135.78K | 177.53K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 4.42M | 4.5M | 4.62M | 4.73M | 4.83M | 4.93M | 5.04M | 5.15M | 5.25M | 5.36M | 5.46M | 5.57M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 2.22K | 2.22K | 5.93K | 5.84K | 5.9K | 6.05K | 109.31K | 6.56M |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 885.59K | 907.37K | 3.99M | 0 |
| Total Assets | 14.98M | 11.14M | 14.15M | 15.3M | 14.87M | 17.12M | 19.03M | 15.25M | 15.44M | 17.47M | 18.94M | 21.41M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 0.68% | -34.92% | -25.61% | 0.33% | -3.66% | -2.03% | 0.45% | -28.78% | -47.63% | -54.51% | -56.54% | -58.16% |
| Total Current Liabilities | 16.4M | 6.05M | 6.65M | 13.25M | 10.34M | 6.68M | 3.68M | 5.04M | 3.92M | 4.57M | 4.2M | 5.85M |
| Accounts Payable | 0 | 0 | 2.61M | 1.87M | 1.32M | 3.25M | 1.35M | 3.6M | 2.62M | 3.24M | 2.66M | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 872.92K | 1.87M | 2.41M | 2.11M | 1.24M | 771.14K | 300.55K | 615.56K | 599.91K | 300.55K | 300.55K | 407.75K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 1M | 1M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 15.53M | 4.17M | 1.83K | 7.79M | 5.71M | 492K | 75 | 1 | 8.04K | 31.34K | 130.38K | 5.44M |
| Current Ratio | 0.63x | 1.07x | 1.41x | 0.78x | 0.96x | 1.80x | 3.76x | 1.99x | 2.34x | 2.43x | 2.20x | 1.56x |
| Quick Ratio | 0.63x | 1.06x | 1.39x | 0.77x | 0.95x | 1.79x | 3.76x | 1.99x | 2.34x | 2.43x | 2.20x | 1.56x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.91K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.91K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 16.4M | 6.05M | 6.65M | 13.25M | 10.34M | 6.68M | 3.68M | 5.04M | 3.92M | 4.57M | 4.2M | 5.86M |
| Total Debt | 872.92K | 1.87M | 2.56M | 2.27M | 1.28M | 824.92K | 373.02K | 625.2K | 623.8K | 339.2K | 362.86K | 417.66K |
| Net Debt | -3.48M | -29.09K | 2.11M | 767.56K | -2.24M | -5.17M | -2.75M | -2.68M | -706.42K | -2.42M | -3.27M | -5.25M |
| Debt / Equity | - | 0.37x | 0.34x | 1.11x | 0.28x | 0.08x | 0.02x | 0.06x | 0.05x | 0.03x | 0.02x | 0.03x |
| Debt / EBITDA | - | 0.23x | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | -0.00x | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -64.39x | - | -44.18x | -40.46x | -23.93x | -330.99x | -386.17x | -400.16x | -167.47x | -137629.50x | - | - |
| Total Equity | -1.42M | 5.09M | 7.51M | 2.05M | 4.53M | 10.44M | 15.35M | 10.2M | 11.51M | 12.91M | 14.75M | 15.55M |
| Equity Growth % | -131.45% | -51.21% | -51.08% | -79.94% | -60.67% | -19.13% | 4.06% | -34.39% | -44.79% | -57.73% | -59.2% | -63.48% |
| Book Value per Share | -0.32 | 1.31 | 1.97 | 0.68 | 3.98 | 10.16 | 16.72 | 15.91 | 18.88 | 21.30 | 24.46 | 25.76 |
| Total Shareholders' Equity | 597.18K | 6.91M | 8.65M | 3.76M | 5.73M | 11.48M | 16.29M | 10.96M | 12.03M | 13.24M | 14.84M | 15.55M |
| Common Stock | 178.07M | 169.39M | 169.03M | 159.96M | 153.04M | 150.47M | 149.08M | 140.71M | 138.65M | 137.78M | 137.76M | 137.46M |
| Retained Earnings | -212.54M | -197.93M | -195.26M | -189.94M | -180.69M | -172.11M | -166.75M | -162.92M | -159.81M | -157.91M | -156.5M | -155.4M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 215.24K | 101.36K | 276.15K | 130.85K | 47.3K | 50.8K | 2.83M | 2.52M | 184.59K | 417.34K | 3.38M | 3.67M |
| Minority Interest | -2.02M | -1.82M | -1.15M | -1.72M | -1.2M | -1.04M | -944.29K | -756.13K | -515.55K | -327.5K | -89.53K | 0 |